World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jan. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
481 Seer, Inc. $142.1 M United States US Healthcare US Biotechnology
482 Black Diamond Therapeutics, Inc. $141.5 M United States US Healthcare US Biotechnology
483 SinoMab BioScience Ltd $140.5 M Hong Kong HK Healthcare HK Biotechnology
484 Lineage Cell Therapeutics, Inc. $140.2 M United States US Healthcare US Biotechnology
485 Santhera Pharmaceuticals Holding AG $139.8 M Switzerland Swiss Healthcare Swiss Biotechnology
486 StemRIM $139.2 M Japan Japanese Healthcare Japanese Biotechnology
487 InflaRx N.V. $137.8 M Germany German Healthcare German Biotechnology
488 Talaris Therapeutics, Inc. $137.4 M

(July 1, 2023)

United States US Healthcare US Biotechnology
489 BioGend Therapeutics Co. Ltd $136.1 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
490 Strongbridge Biopharma plc $135.7 M

(Oct. 1, 2021)

United States US Healthcare US Biotechnology
491 Mabpharm Ltd $135.4 M China Chinese Healthcare Chinese Biotechnology
492 Selecta Biosciences, Inc. $135.2 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
493 Genovis AB $134.9 M Sweden Swedish Healthcare Swedish Biotechnology
494 BriaCell Therapeutics Corp $131.7 M

(Dec. 1, 2021)

Canada Canadian Healthcare Canadian Biotechnology
495 Idorsia Ltd $131.5 M Switzerland Swiss Healthcare Swiss Biotechnology
496 G1 Therapeutics, Inc. $131.2 M

(July 1, 2024)

United States US Healthcare US Biotechnology
497 aTyr Pharma, Inc. $131.1 M United States US Healthcare US Biotechnology
498 Heidelberg Pharma AG $130.7 M Germany German Healthcare German Biotechnology
499 Scancell Holdings plc $129.4 M United Kingdom UK Healthcare UK Biotechnology
500 NervGen Pharma Corp $129.1 M Canada Canadian Healthcare Canadian Biotechnology
501 Sesen Bio, Inc. $128.0 M

(March 1, 2023)

United States US Healthcare US Biotechnology
502 Faron Pharmaceuticals OY $127.9 M

(July 1, 2024)

Finland Finnish Healthcare Finnish Biotechnology
503 SYN-TECH Chem. & Pharm. Co. Ltd $127.6 M

(July 1, 2024)

Taiwan Taiwanese Healthcare Taiwanese Biotechnology
504 Cabaletta Bio, Inc. $126.6 M United States US Healthcare US Biotechnology
505 Diamyd Medical AB $126.1 M

(July 1, 2024)

Sweden Swedish Healthcare Swedish Biotechnology
506 Paratek Pharmaceuticals, Inc. $125.7 M

(July 1, 2023)

United States US Healthcare US Biotechnology
507 CellSource Co. Ltd $125.6 M Japan Japanese Healthcare Japanese Biotechnology
508 Japan Tissue Engineering Co. Ltd $124.7 M Japan Japanese Healthcare Japanese Biotechnology
509 Infant Bacterial Therapeutics AB $124.4 M

(July 1, 2024)

Sweden Swedish Healthcare Swedish Biotechnology
510 F-star Therapeutics, Inc. $123.7 M

(Jan. 1, 2023)

United Kingdom UK Healthcare UK Biotechnology

Top Biotechnology Companies in the World as of Jan. 01, 2025

481. Seer, Inc.

Company Profile: Seer, Inc.
Market Cap (USD): $142.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

482. Black Diamond Therapeutics, Inc.

Company Profile: Black Diamond Therapeutics, Inc.
Market Cap (USD): $141.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

483. SinoMab BioScience Ltd

Company Profile: SinoMab BioScience Ltd
Market Cap (USD): $140.5 M
Country: Hong Kong
Sector: HK Healthcare
Industry: HK Biotechnology

484. Lineage Cell Therapeutics, Inc.

Company Profile: Lineage Cell Therapeutics, Inc.
Market Cap (USD): $140.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

485. Santhera Pharmaceuticals Holding AG

Company Profile: Santhera Pharmaceuticals Holding AG
Market Cap (USD): $139.8 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

486. StemRIM

Company Profile: StemRIM
Market Cap (USD): $139.2 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

487. InflaRx N.V.

Company Profile: InflaRx N.V.
Market Cap (USD): $137.8 M
Country: Germany
Sector: German Healthcare
Industry: German Biotechnology

488. Talaris Therapeutics, Inc.

Company Profile: Talaris Therapeutics, Inc.
Market Cap (USD): $137.4 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

489. BioGend Therapeutics Co. Ltd

Company Profile: BioGend Therapeutics Co. Ltd
Market Cap (USD): $136.1 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

490. Strongbridge Biopharma plc

Company Profile: Strongbridge Biopharma plc
Market Cap (USD): $135.7 M (Oct. 1, 2021)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

491. Mabpharm Ltd

Company Profile: Mabpharm Ltd
Market Cap (USD): $135.4 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

492. Selecta Biosciences, Inc.

Company Profile: Selecta Biosciences, Inc.
Market Cap (USD): $135.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

493. Genovis AB

Company Profile: Genovis AB
Market Cap (USD): $134.9 M
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Biotechnology

494. BriaCell Therapeutics Corp

Company Profile: BriaCell Therapeutics Corp
Market Cap (USD): $131.7 M (Dec. 1, 2021)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Biotechnology

495. Idorsia Ltd

Company Profile: Idorsia Ltd
Market Cap (USD): $131.5 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

496. G1 Therapeutics, Inc.

Company Profile: G1 Therapeutics, Inc.
Market Cap (USD): $131.2 M (July 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

497. aTyr Pharma, Inc.

Company Profile: aTyr Pharma, Inc.
Market Cap (USD): $131.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

498. Heidelberg Pharma AG

Company Profile: Heidelberg Pharma AG
Market Cap (USD): $130.7 M
Country: Germany
Sector: German Healthcare
Industry: German Biotechnology

499. Scancell Holdings plc

Company Profile: Scancell Holdings plc
Market Cap (USD): $129.4 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

500. NervGen Pharma Corp

Company Profile: NervGen Pharma Corp
Market Cap (USD): $129.1 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Biotechnology

501. Sesen Bio, Inc.

Company Profile: Sesen Bio, Inc.
Market Cap (USD): $128.0 M (March 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

502. Faron Pharmaceuticals OY

Company Profile: Faron Pharmaceuticals OY
Market Cap (USD): $127.9 M (July 1, 2024)
Country: Finland
Sector: Finnish Healthcare
Industry: Finnish Biotechnology

503. SYN-TECH Chem. & Pharm. Co. Ltd

Company Profile: SYN-TECH Chem. & Pharm. Co. Ltd
Market Cap (USD): $127.6 M (July 1, 2024)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

504. Cabaletta Bio, Inc.

Company Profile: Cabaletta Bio, Inc.
Market Cap (USD): $126.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

505. Diamyd Medical AB

Company Profile: Diamyd Medical AB
Market Cap (USD): $126.1 M (July 1, 2024)
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Biotechnology

506. Paratek Pharmaceuticals, Inc.

Company Profile: Paratek Pharmaceuticals, Inc.
Market Cap (USD): $125.7 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

507. CellSource Co. Ltd

Company Profile: CellSource Co. Ltd
Market Cap (USD): $125.6 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

508. Japan Tissue Engineering Co. Ltd

Company Profile: Japan Tissue Engineering Co. Ltd
Market Cap (USD): $124.7 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

509. Infant Bacterial Therapeutics AB

Company Profile: Infant Bacterial Therapeutics AB
Market Cap (USD): $124.4 M (July 1, 2024)
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Biotechnology

510. F-star Therapeutics, Inc.

Company Profile: F-star Therapeutics, Inc.
Market Cap (USD): $123.7 M (Jan. 1, 2023)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology